Brief: Somalogic Announces Preliminary Revenue For Full Year 2021 Above Guidance Range
11/01/2022 12:09
Jan 11 (Reuters) - Somalogic Inc SLGC.O :
* SOMALOGIC ANNOUNCES PRELIMINARY REVENUE FOR FULL YEAR 2021 ABOVE GUIDANCE
RANGE
* SEES FY REVENUE UP MORE THAN 41 PERCENT
* SEES FY REVENUE MORE THAN $79 MILLION
Source text for Eikon: ID:nGNX3YS6RG
Further company coverage: SLGC.O
Recent news on Somalogic
See all newsBrief: Somalogic Stockholders Vote To Approve Standard Biotools Transaction At Special Meeting
Brief: Madryn Asset Management Demands Somalogic’S Board Address Repeated, Unprecedented Adjournments Of Tainted Special Meeting
Brief: Madryn Asset Management Says It Urges All Somalogic Shareholders To Oppose Transaction With Standard Biotools
Brief: Madryn Asset Management Urges Shareholders To Vote “Against” The Proposed Merger And Allow Somalogic To Pursue Value-Enhancing Alternatives
Brief: Somalogic Board Reiterates Value-Maximizing Transaction With Standard Biotools Is In Best Interests Of All Stockholders